Hls Therapeutics Inc opened trading today at $5.10 and closed at $5.01. Intraday prices ranged from a low of $5.01 to a high of $5.14.

The price eased -2.34% from the previous day's close of $5.13.

Today across North America, the TSX Composite closed -0.73% at 22199.13, the S&P 500 closed -0.95% at 5160.64, the Dow Jones Industrial Average closed -1.09% at 38461.51 and the Nasdaq Composite closed -0.84% at 16170.36.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

A total of 3,000 shares was traded during the last trading day, with total trades of 9, with an average volume of 12,334 over the last 5 days.

Trading across the entire TSX saw 2,898 price advancers against 2,320 declines and 129 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.34 (November 27,2023). Moreover, in the last 12 months, Hls Therapeutics Inc's shares have shrunken -17.87 percent, while they have raised 26.84% this year.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $163.76 million on a float of 31,921 shares outstanding. Its annual EPS is $-0.85.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Hls Therapeutics Inc's average recommendation is "Moderate Buy" based on 5.00 analysts according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..